Literature DB >> 26282455

Undiagnosed cardiac sarcoidosis presenting as complete heart block and ventricular arrhythmia.

Kyle Mcbeath1, Shohreh Honarbakhsh1, Mohammad Chowdhury1, Fahad Farooqi1.   

Abstract

Cardiac involvement in sarcoidosis has been reported to be as high as 50% of cases and it is well documented that it is associated with a poorer prognosis. Early recognition and treatment is key to reducing the risk of fatal arrhythmias and heart failure. We report a case of undiagnosed systemic sarcoidosis in a young man who initially presented to the emergency department with complete heart block in the context of preserved biventricular systolic function, and then again with ventricular tachycardia and moderately impaired left ventricular systolic function. We discuss how 18F-fluorodeoxyglucose positron emission tomography with CT was used for accurate diagnosis and how its role in the management of sarcoidosis has expanded with recent evidence suggesting it to be a mainstay of management and disease monitoring in cardiac sarcoidosis. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282455      PMCID: PMC4550861          DOI: 10.1136/bcr-2015-211736

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  18F-FDG PET and PET/CT in fever of unknown origin.

Authors:  Johannes Meller; Carsten-Oliver Sahlmann; Alexander Konrad Scheel
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

Review 2.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

3.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

Authors:  A Uemura; S Morimoto; S Hiramitsu; Y Kato; T Ito; H Hishida
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

4.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

Review 5.  The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.

Authors:  George Youssef; Eugene Leung; Ilias Mylonas; Pablo Nery; Kathryn Williams; Gerald Wisenberg; Karen Y Gulenchyn; Robert A Dekemp; Jean Dasilva; David Birnie; George A Wells; Rob S B Beanlands
Journal:  J Nucl Med       Date:  2012-01-06       Impact factor: 10.057

6.  Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.

Authors:  Y Yazaki; M Isobe; M Hiroe; S Morimoto; S Hiramitsu; T Nakano; T Izumi; M Sekiguchi
Journal:  Am J Cardiol       Date:  2001-11-01       Impact factor: 2.778

Review 7.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

8.  Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis.

Authors:  M Sekiguchi; Y Numao; M Imai; T Furuie; R Mikami
Journal:  Jpn Circ J       Date:  1980-04

9.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Authors:  Ron Blankstein; Michael Osborne; Masanao Naya; Alfonso Waller; Chun K Kim; Venkatesh L Murthy; Pedram Kazemian; Raymond Y Kwong; Michifumi Tokuda; Hicham Skali; Robert Padera; Jon Hainer; William G Stevenson; Sharmila Dorbala; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

Review 10.  Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies.

Authors:  Sat Sharma
Journal:  Curr Opin Pulm Med       Date:  2009-09       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.